BRISK-FL Study with investigational compound brivanib in hepatocellular carcinoma does not meet overall survival primary endpoint
19 July 2012 | By Bristol-Myers Squibb Company
Results of the phase III BRISK-FL clinical trial...
List view / Grid view
News
HIV care collaborative with Atlanta, Houston and Philadelphia health departments
19 July 2012 | By Merck
Initiative is designed to improve access to care in support of U.S. National HIV/AIDS Strategy...
Nestlé Health Science develops brain health portfolio with new investment
18 July 2012 | By Nestlé
Nestlé Health Science has acquired a stake in a US firm Accera...
Sanofi announces 2012 Patient Group Bursary winners
18 July 2012 | By Sanofi
Ataxia UK, Crohn’s & Colitis UK & Muscular Dystrophy Campaign share £50,000 to help better the lives of patients throughout the UK...
Myeloma UK announces opening of an innovative new study with a novel drug combination
18 July 2012 | By Myeloma UK
Myeloma UK announced the opening of MUK three...
Catalent expert will present at the “Drug Development Decisions: The NDA Simulation Workshop” for the PERI
18 July 2012 | By Catalent Pharma Solutions
Carolyn Finkle, VP, Global Regulatory Consulting to present...
Meeting scheduled for insulin degludec and insulin degludec/insulin aspart
18 July 2012 | By Novo Nordisk
Meeting scheduled to discuss the NDA for the ultra-long-acting insulin degludec & insulin degludec/insulin aspart....
Merck launches Richard T. Clark Fellowship program with PSI Partnership
17 July 2012 | By Merck
Five Inaugural Fellows Will Use Skills and Talents to Help Enhance Quality and Scalability of PSI’s Country Operations...
GlaxoSmithKline and Amicus Therapeutics expand Fabry disease collaboration
17 July 2012 | By GlaxoSmithKline
Fabry products to be commercialised by Amicus in US and by GSK ex-US...
Biogen Idec announces collaboration with leading research institutions to sequence genomes of patients with ALS
17 July 2012 | By Biogen Idec
Labs at Duke University and HudsonAlpha Institute to lead research consortium...
GSK to acquire Human Genome Sciences for US$14.25 per share in cash
16 July 2012 | By GlaxoSmithKline
GSK to acquire full ownership of BENLYSTA®, albiglutide and darapladib...
AstraZeneca reports terms of David Brennan’s retirement
16 July 2012 | By AstraZeneca
AstraZeneca reported on the remuneration arrangements relating to David Brennan’s retirement...
GlaxoSmithKline celebrates its role in supporting the biggest anti-doping operation in the history of the Olympic Games
16 July 2012 | By GlaxoSmithKline
GSK launches new advertising campaign...
U.S. FDA approves Gilead ’s Truvada® for reducing the risk of acquiring HIV
16 July 2012 | By Gilead Sciences
The U.S. FDA has approved once-daily oral Truvada®...
Ilka Diester wins Boehringer Ingelheim’s FENS Award 2012 for Exceptional Research in Neuroscience
16 July 2012 | By Boehringer Ingelheim
This year's Boehringer Ingelheim FENS Award was granted to Ilka Diester...
